|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBOOKCENTRAL_ocn761307745 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
100827s2011 nyua ob 001 0 eng |
| 010 |
|
|
|a 2020678359
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d YDXCP
|d E7B
|d OCLCF
|d NLGGC
|d EBLCP
|d DEBSZ
|d AZK
|d MERUC
|d AGLDB
|d MOR
|d PIFAG
|d ZCU
|d U3W
|d STF
|d WRM
|d VTS
|d NRAMU
|d ICG
|d VT2
|d AU@
|d WYU
|d A6Q
|d DKC
|d UKCRE
|d BOL
|d N$T
|d OCLCO
|d VLY
|d AJS
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 961534321
|a 962711624
|a 988523497
|a 992002951
|a 1037944403
|a 1038689371
|a 1045491739
|a 1055378407
|a 1058175500
|a 1066407900
|a 1081199291
|a 1083559348
|a 1114474655
|a 1119550660
|a 1153524977
|a 1162422950
|a 1259275787
|
| 020 |
|
|
|a 9781611223606
|q (ebook)
|
| 020 |
|
|
|a 1611223601
|
| 020 |
|
|
|z 9781611220711
|q (hbk.)
|
| 020 |
|
|
|z 1611220718
|
| 029 |
1 |
|
|a AU@
|b 000051366736
|
| 029 |
1 |
|
|a AU@
|b 000066119495
|
| 029 |
1 |
|
|a DEBBG
|b BV043098871
|
| 029 |
1 |
|
|a DEBBG
|b BV044087764
|
| 029 |
1 |
|
|a DEBSZ
|b 421511230
|
| 029 |
1 |
|
|a DEBSZ
|b 449538915
|
| 029 |
1 |
|
|a NZ1
|b 15025310
|
| 035 |
|
|
|a (OCoLC)761307745
|z (OCoLC)961534321
|z (OCoLC)962711624
|z (OCoLC)988523497
|z (OCoLC)992002951
|z (OCoLC)1037944403
|z (OCoLC)1038689371
|z (OCoLC)1045491739
|z (OCoLC)1055378407
|z (OCoLC)1058175500
|z (OCoLC)1066407900
|z (OCoLC)1081199291
|z (OCoLC)1083559348
|z (OCoLC)1114474655
|z (OCoLC)1119550660
|z (OCoLC)1153524977
|z (OCoLC)1162422950
|z (OCoLC)1259275787
|
| 043 |
|
|
|a n-us---
|
| 050 |
0 |
0 |
|a HD9666.4
|
| 072 |
|
7 |
|a BUS
|x 070000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 338.4/361510973
|2 22
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Generic drugs :
|b the pay-for-delay problem /
|c Christina M. Curtin, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical/Nova Science Publishers,
|c [2011]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 340 |
|
|
|g polychrome.
|2 rdacc
|0 http://rdaregistry.info/termList/RDAColourContent/1003
|
| 347 |
|
|
|a data file
|
| 490 |
1 |
|
|a Public health in the 21st century
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a GENERIC DRUGS: THE PAY-FOR-DELAY PROBLEM ; GENERIC DRUGS: THE PAY-FOR- DELAY PROBLEM; CONTENTS; PREFACE; PAY-FOR-DELAY: HOW DRUG COMPANY PAY-OFFS COST CONSUMERS BILLIONS; SUMMARY ; RECOMMENDATION; BACKGROUND ; FINDINGS FROM PHARMACEUTICAL AGREEMENT FILINGS FROM FY2004 THROUGH FY2009; STUDY METHODOLOGY ; How Staff Calculated the Additional Delay in Generic Entry Associated with Agreements that Involved Compensation from the Brand to the Generic ; How Staff Calculated the Estimate of 3.5 Billion Annually that Consumers Lose due to Pay-For-Delay Agreements.
|
| 505 |
8 |
|
|a (1) Consumer savings from generic competition (2) Likelihood of Settlements with Payment to Delay, and the Length of Delay; (3) Sales Volume of Drugs for which Settlements are Likely ; (4) Final Estimate Calculation ; Results with Varied Assumptions ; End Notes ; "PAY-FOR-DELAY" SETTLEMENTS IN THE PHARMACEUTICAL INDUSTRY: HOW CONGRESS CAN STOP ANTICOMPETITIVE CONDUCT, PROTECT CONSUMERS' WALLETS, AND HELP PAY FOR HEALTH CARE REFORM (THE 35 BILLION SOLUTION) ; A BRIEF HISTORY ; NEW FTC ANALYSIS OF EMPIRICAL DATA ; Savings to Consumers and the Federal Government ; ENCOURAGING SIGNS.
|
| 505 |
8 |
|
|a LOOKING FORWARDAPPENDIX: CALCULATION OF CONSUMER SAVINGS ; Consumer Savings from Generic Competition ; Likelihood of Settlements with Payment to Delay, and the Length of Delay ; Sales Volume of Drugs for which Settlements are Likely ; Final Estimate Calculation ; Results with Varied Assumptions ; End Notes ; STATEMENT OF THE FEDERAL TRADE COMMISSION, BEFORE THE SUBCOMMITTEE ON COURTS AND COMPETITION POLICY, HEARING ON "ANTICOMPETITIVE PAY-FOR-DELAY SETTLEMENTS IN THE PHARMACEUTICAL INDUSTRY: WHY CONSUMERS AND THE FEDERAL GOVERNMENT ARE PAYING TOO MUCH FOR PRESCRIPTION DRUGS."
|
| 505 |
8 |
|
|a I. THE NEED FOR A LEGISLATIVE SOLUTION A. Permissive Court Decisions have Made Pay-for-Delay Settlements Commonplace in Hatch-Waxman Patent Cases ; B. The Profitability of Delaying Generic Entry Means that these Agreements will become More Prevalent ; C. Pay-For-Delay Settlements Impose Enormous Costs on Consumers and the Health Care System ; D. Permissive Legal Treatment of Pay-for-Delay Settlements Undermines the Hatch-Waxman Act ; E. Legislation is Likely to be Swifter and More Comprehensive than Litigation.
|
| 505 |
8 |
|
|a II. THE ARGUMENTS AGAINST BARRING EXCLUSION PAYMENTS ARE CONTRADICTED BY EXPERIENCE IN THE MARKET III. THE LEGISLATIVE REMEDY; CONCLUSION ; End Notes ; TESTIMONY OF HEATHER BRESCH, CHIEF OPERATING OFFICER, MYLAN, INC., BEFORE THE SUBCOMMITTEE ON COURTS AND COMPETITION POLICY, HEARING ON "PAY TO DELAY: ARE PATENT SETTLEMENTS THAT DELAY GENERIC DRUG MARKET ENTRY ANTICOMPETITIVE" ; A BRIEF HISTORY OF HATCH-WAXMAN ; AUTHORIZED GENERICS ; PATENT SETTLEMENTS.
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Generic drugs
|x Prices.
|
| 650 |
|
0 |
|a Drugs
|x Prices.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|z United States.
|
| 650 |
|
6 |
|a Médicaments génériques
|x Prix.
|
| 650 |
|
6 |
|a Médicaments
|x Prix.
|
| 650 |
|
6 |
|a Industrie pharmaceutique
|z États-Unis.
|
| 650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Industries
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a Drugs
|x Prices
|2 fast
|
| 650 |
|
7 |
|a Generic drugs
|x Prices
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical industry
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 700 |
1 |
|
|a Curtin, Christina M.
|
| 776 |
0 |
8 |
|i Print version:
|t Generic drugs.
|d New York : Nova Biomedical/Nova Science Publishers, ©2011
|z 9781611220711
|w (DLC) 2010036382
|
| 830 |
|
0 |
|a Public health in the 21st century series.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3018688
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3018688
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10661626
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 399726
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 7267528
|
| 994 |
|
|
|a 92
|b IZTAP
|
